Pfizer (NYSE:PFE)

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

Major Pharma Sees Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Pfizer Once Again the Most Shorted Dow Stock

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

The stock market has experienced yet another 5% correction after hitting all-time highs just in July. What really stands out for 2019, particularly if you just followed the emotions of ...
Read Full Story »

Is GlycoMimetics’ Sickle Cell Study Done For?

GlycoMimetics Inc. (NASDAQ: GLYC) shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease (SCD) trial in conjunction with Pfizer Inc. (NYSE: PFE). SCD ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

Stocks were indicated to open lower on Tuesday after a mixed performance on Monday. The market is getting ready for the Federal Reserve to cut interest rates on Wednesday, and ...
Read Full Story »

What to Watch When Merck and Pfizer Report Early on Tuesday

Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) are each scheduled to release their second-quarter financial results before the markets open on Tuesday. These are just a ...
Read Full Story »

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Mylan N.V. (NASDAQ: MYL) released its second-quarter financial results before the markets opened on Monday. The pharmaceutical giant also announced a major update to its business involving Pfizer Inc. (NYSE: ...
Read Full Story »

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. The Dow is just off its all-time high, while earnings season ...
Read Full Story »

This Stock Is Killing the Dow

Only three of the 30 Dow Jones industrial average components are down this year. Pfizer Inc. (NYSE: PFE) is barely off, by 1.28% to $43.09. 3M Co. (NYSE: MMM) is ...
Read Full Story »

Short Sellers Up the Ante in Big Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Intel Overtakes Pfizer as Most Shorted Dow Stock

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

Big Pharma Sees Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 5 Most Shorted Dow Stocks

It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or ...
Read Full Story »

Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates

The ongoing trade and tariff issues most likely will have the greatest impact when companies report second-quarter earnings. Needless to say, investors are wary of the constant back and forth ...
Read Full Story »